The role of inflammatory cells in angiogenesis in multiple myeloma

Domenico Ribatti, Angelo Vacca

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Both innate and adaptive immune cells are involved in the mechanisms of endothelial cell proliferation, migration and activation, via production and release of a large spectrum of pro-angiogenic mediators, thus creating the specific microenvironment that favors increased rate of tissue vascularization. In this article, we focus on the immune cell component of the angiogenic process occurring during multiple myeloma progression. We also provide information on some antiangiogenic properties of immune cells that may be applied for a potential pharmacological use as anti-angiogenic agents in the disease treatment.

Original languageEnglish
Title of host publicationInflammation and Cancer
PublisherSpringer New York LLC
Pages361-376
Number of pages16
Volume816
ISBN (Print)9783034808361
DOIs
Publication statusPublished - 2014

Publication series

NameAdvances in Experimental Medicine and Biology
Volume816
ISSN (Print)00652598
ISSN (Electronic)22148019

Fingerprint

Endothelial cells
Cell proliferation
Multiple Myeloma
Chemical activation
Tissue
Cellular Structures
Cell Movement
Endothelial Cells
Cell Proliferation
Pharmacology

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Ribatti, D., & Vacca, A. (2014). The role of inflammatory cells in angiogenesis in multiple myeloma. In Inflammation and Cancer (Vol. 816, pp. 361-376). (Advances in Experimental Medicine and Biology; Vol. 816). Springer New York LLC. https://doi.org/10.1007/978-3-0348-0837-8_14

The role of inflammatory cells in angiogenesis in multiple myeloma. / Ribatti, Domenico; Vacca, Angelo.

Inflammation and Cancer. Vol. 816 Springer New York LLC, 2014. p. 361-376 (Advances in Experimental Medicine and Biology; Vol. 816).

Research output: Chapter in Book/Report/Conference proceedingChapter

Ribatti, D & Vacca, A 2014, The role of inflammatory cells in angiogenesis in multiple myeloma. in Inflammation and Cancer. vol. 816, Advances in Experimental Medicine and Biology, vol. 816, Springer New York LLC, pp. 361-376. https://doi.org/10.1007/978-3-0348-0837-8_14
Ribatti D, Vacca A. The role of inflammatory cells in angiogenesis in multiple myeloma. In Inflammation and Cancer. Vol. 816. Springer New York LLC. 2014. p. 361-376. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-3-0348-0837-8_14
Ribatti, Domenico ; Vacca, Angelo. / The role of inflammatory cells in angiogenesis in multiple myeloma. Inflammation and Cancer. Vol. 816 Springer New York LLC, 2014. pp. 361-376 (Advances in Experimental Medicine and Biology).
@inbook{c36a802f66be49d5922c6acff953a419,
title = "The role of inflammatory cells in angiogenesis in multiple myeloma",
abstract = "Both innate and adaptive immune cells are involved in the mechanisms of endothelial cell proliferation, migration and activation, via production and release of a large spectrum of pro-angiogenic mediators, thus creating the specific microenvironment that favors increased rate of tissue vascularization. In this article, we focus on the immune cell component of the angiogenic process occurring during multiple myeloma progression. We also provide information on some antiangiogenic properties of immune cells that may be applied for a potential pharmacological use as anti-angiogenic agents in the disease treatment.",
author = "Domenico Ribatti and Angelo Vacca",
year = "2014",
doi = "10.1007/978-3-0348-0837-8_14",
language = "English",
isbn = "9783034808361",
volume = "816",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York LLC",
pages = "361--376",
booktitle = "Inflammation and Cancer",

}

TY - CHAP

T1 - The role of inflammatory cells in angiogenesis in multiple myeloma

AU - Ribatti, Domenico

AU - Vacca, Angelo

PY - 2014

Y1 - 2014

N2 - Both innate and adaptive immune cells are involved in the mechanisms of endothelial cell proliferation, migration and activation, via production and release of a large spectrum of pro-angiogenic mediators, thus creating the specific microenvironment that favors increased rate of tissue vascularization. In this article, we focus on the immune cell component of the angiogenic process occurring during multiple myeloma progression. We also provide information on some antiangiogenic properties of immune cells that may be applied for a potential pharmacological use as anti-angiogenic agents in the disease treatment.

AB - Both innate and adaptive immune cells are involved in the mechanisms of endothelial cell proliferation, migration and activation, via production and release of a large spectrum of pro-angiogenic mediators, thus creating the specific microenvironment that favors increased rate of tissue vascularization. In this article, we focus on the immune cell component of the angiogenic process occurring during multiple myeloma progression. We also provide information on some antiangiogenic properties of immune cells that may be applied for a potential pharmacological use as anti-angiogenic agents in the disease treatment.

UR - http://www.scopus.com/inward/record.url?scp=84959237996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959237996&partnerID=8YFLogxK

U2 - 10.1007/978-3-0348-0837-8_14

DO - 10.1007/978-3-0348-0837-8_14

M3 - Chapter

AN - SCOPUS:84959237996

SN - 9783034808361

VL - 816

T3 - Advances in Experimental Medicine and Biology

SP - 361

EP - 376

BT - Inflammation and Cancer

PB - Springer New York LLC

ER -